Since its establishment in July 2024, phagogen has been continuously conducting research and development through startup activities and securing R&D projects.
Efferocytosis control technology or materials may provide hope for the treatment of arteriosclerosis
Efferocytosis is the process by which dying cells are removed by phagocytic cells such as macrophages.
Atherosclerosis is a condition in which the walls of the arteries become thickened and narrowed due to the buildup of fatty deposits, cholesterol, and other substances
Copyright © Phagogen. All Rights Reserved.